Middle East and Africa Prophylaxis of Organ Rejection Market - Opportunities, Share, Growth and Competitive Analysis 2029
Middle East and Africa Prophylaxis of Organ Rejection Market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 2.0% in the forecast period of 2022 to 2029 and is expected to reach USD 69.23 million by 2029 from USD 59.81 million in 2021.
Industry Analysis
The term prophylaxis means treatment given or
action taken to prevent disease. The prophylaxis of organ rejection, refers to
the prevention of organ rejection by use of medicines. The patients who undergo
transplantation, must be maintained on an immunosuppression regimen for
rejection prophylaxis to help ensure graft survival. The transplant rejection
is a process, in which a transplant recipient’s immunity the current rejection
prophylaxis implements use of calcineurin inhibitors, mTOR inhibitors,
antimetabolite agents, and corticosteroids. The treatment agents improve the
short term consequences of the organ transplantation, but certain improvements.
The recipient patients, who have undergone solid organ transplantation, should
take anti-rejection medicines. This is because the immunity system would
destroy the transplanted organ.
The driving factors responsible for the growth
of the Middle East and Africa prophylaxis of organ rejection market are the
increased prevalence of organ transplantation, rise in surgical procedures,
rise in recipient population and product launches. However, the factors that
are expected to restrain the market are the rise in the cost of the
transplantation procedure, lack of awareness about organ transplantation and
the risks included while the patient receives the transplanted organ.
Global Middle East and Africa
Prophylaxis of Organ Rejection Market Scope
Middle East and
Africa prophylaxis of organ rejection market is categorized into seven segments:
cause, treatment, route of administration, organ, patient type, end user and
distribution channel.
On the basis of cause, the Middle East and
Africa prophylaxis of organ rejection market is segmented into
·
Epidemiologic
exposure,
·
Antibacterial
prophylaxis,
·
Prophylaxis
against other pathogens
·
Others.
On the basis of treatment, the Middle East and
Africa prophylaxis of organ rejection market is segmented into
·
Outpatient
immunosuppressant,
·
Inpatient
immunosuppressant and
·
Others.
On the basis of route of administration, the
Middle East and Africa prophylaxis of organ rejection market is segmented into
·
Oral
·
Intravenous.
On the basis of organ, the Middle East and
Africa prophylaxis of organ rejection market is segmented into
·
Kidney,
·
Liver,
·
Heart,
·
Lung
·
Others.
On the basis of patient type, the Middle East
and Africa prophylaxis of organ rejection market is segmented into
·
Paediatric
·
Adults.
On the basis of end user, the Middle East and
Africa prophylaxis of organ rejection market is segmented into
·
Hospitals,
·
Clinics,
·
Home
healthcare
·
Others.
On the basis of distribution channel, the
Middle East and Africa prophylaxis of organ rejection market is segmented into
·
Direct
tenders,
·
Pharmacy
stores
·
Others.
Get the sample copy of the report here: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=middle-east-and-africa-prophylaxis-of-organ-rejection-market
Middle East and Africa Prophylaxis of
Organ Rejection Market Regional Analysis/Insights
Middle East and
Africa prophylaxis of organ rejection market is categorized into seven
segments: cause, treatment, route of administration, organ, patient type, end
user and distribution channel.
The countries covered in the Middle-East and
Africa Prophylaxis of Organ Rejection market report are the
·
South Africa,
·
Saudi Arabia,
·
UAE,
·
Egypt,
·
Israel
·
Rest of Middle East
·
Africa.
Middle East and
Africa is expected to grow with the substantial growth rate in the forecast
period of 2021 to 2029 as Middle East and Africa counties are major developing
countries and focus on increasing R&D activities in pharma and biotech
sector and increase outsourcing services. South Africa is expected to dominate
in the market in the Middle East and Africa market.
Competitive Landscape and Middle East
and Africa Prophylaxis of Organ Rejection Market Share Analysis
Middle East and Africa prophylaxis of organ
rejection competitive landscape provides details by competitor. Details
included are company overview, company financials, revenue generated, market
potential, investment in research and development, new market initiatives,
production sites and facilities, company strengths and weaknesses, product
launch, product trials pipelines, product approvals, patents, product width and
breath, application dominance, technology lifeline curve. The above data points
provided are only related to the company’s focus related to cleanroom particle
counters market.
The
major companies providing the Middle East and Africa Prophylaxis of Organ
Rejection are
·
Panacea Biotec,
·
WOCKHARDT,
·
Accord-UK Ltd,
·
Veloxis Pharmaceuticals, Inc,
·
Astellas Pharma Inc,
·
Novartis AG,
·
Bristol-Myers Squibb Company,
·
Dr Reddy’s Laboratories, Ltd,
·
Viatris Inc,
·
Glenmark,
·
Biocon,
·
Pfizer Inc,
·
Mayne Pharma Group Limited,
·
Hikma Pharmaceuticals PLC,
·
AbbVie Inc.,
·
Apotex Inc,
·
Zydus Pharmaceuticals, Inc,
·
CSL Behring
·
Among others.
Get Full
Access of reports @ https://www.databridgemarketresearch.com/reports/middle-east-and-africa-prophylaxis-of-organ-rejection-market
MAJOR TOC OF THE REPORT
Ø Chapter One: Introduction
Ø Chapter Two: Market Segmentation
Ø Chapter Three: Market Overview
Ø Chapter Four: Executive Summary
Ø Chapter Five: Premium Insights
Ø Chapter Six: Middle East and Africa
Prophylaxis of Organ Rejection Market by Product & Procedure type
Get TOC
Details: https://www.databridgemarketresearch.com/toc/?dbmr=middle-east-and-africa-prophylaxis-of-organ-rejection-market
Browse Related Reports @
About
Us:-
Data Bridge Market Research set forth itself as an unconventional and neoteric
Market research and consulting firm with unparalleled level of resilience and
integrated approaches. We are determined to unearth the best market
opportunities and foster efficient information for your business to thrive in
the market
Contact
Us: -
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
Comments
Post a Comment